Crossmark

Mapping Dermatology Life Quality Index (DLQI) scores to EQ-5D utility scores using data of patients with atopic dermatitis from the National Health and Wellness Study

Crossref DOI link: https://doi.org/10.1007/s11136-020-02499-1

Published Online: 2020-04-15

Published Print: 2020-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Vilsbøll, Andreas Westh

Kragh, Nana

Hahn-Pedersen, Julie

Jensen, Cathrine Elgaard
Funding

Funding for this research was provided by:

Leo Pharma
License Information

Text and Data Mining valid from 2020-04-15

Version of Record valid from 2020-04-15
More Information

Article History

Accepted: 4 April 2020

First Online: 15 April 2020

Compliance with ethical standards

:

: Author A (AWV) was sponsored by Leo Pharma and is an employee of Leo Pharma. Author B (NK) and author C (JHP) are employees of Leo Pharma. None of the authors have any conflict of interest to declare.

: The study was approved by the Ethics Committee/Institutional Review Board (IRB)/Independent Ethics Committee (IEC), and performed in accordance with various ethical principles [], guidelines [], practices [], legislation, and regulations. All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

: Written informed consent was obtained from all individual participants included in the study.

Document is current

Any future updates will be listed below